255
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Diagnostic capacity of miRNAs in neonatal sepsis: a systematic review and meta-analysis

, &
Article: 2345850 | Received 04 Sep 2023, Accepted 16 Apr 2024, Published online: 07 May 2024

References

  • Shane AL, Sánchez PJ, Stoll BJ. Neonatal sepsis. Lancet. 2017;390(10104):1770–1780. doi: 10.1016/s0140-6736(17)31002-4.
  • Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet. 2015;385(9966):430–440. doi: 10.1016/s0140-6736(14)61698-6.
  • Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, et al. The global burden of paediatric and neonatal sepsis: a systematic review. Lancet Respir Med. 2018;6(3):223–230. doi: 10.1016/s2213-2600(18)30063-8.
  • Tat Trung N, Van Tong H, Lien TT, et al. Clinical utility of an optimised multiplex real-time PCR assay for the identification of pathogens causing sepsis in Vietnamese patients. Int J Infect Dis. 2018;67:122–128. doi: 10.1016/j.ijid.2017.12.015.
  • Celik IH, Hanna M, Canpolat FE, et al. Diagnosis of neonatal sepsis: the past, present and future. Pediatr Res 2022;91(2):337–350. doi: 10.1038/s41390-021-01696-z.
  • Kingsley SMK, Bhat BV. Role of microRNAs in sepsis. Inflamm Res. 2017;66(7):553–569. doi: 10.1007/s00011-017-1031-9.
  • Fouda E, Elrazek Midan DA, Ellaban R, et al. The diagnostic and prognostic role of miRNA 15b and miRNA 378a in neonatal sepsis. Biochem Biophys Rep. 2021;26:100988. doi: 10.1016/j.bbrep.2021.100988.
  • Ernst LM, Mithal LB, Mestan K, et al. Umbilical cord miRNAs to predict neonatal early onset sepsis. PLOS One. 2021;16(5):e0249548. doi: 10.1371/journal.pone.0249548.
  • Wang D, Han L. Downregulation of miR-1184 serves as a diagnostic biomarker in neonatal sepsis and regulates LPS-induced inflammatory response by inhibiting IL-16 in monocytes. Exp Ther Med. 2021;21(4):350. doi: 10.3892/etm.2021.9781.
  • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open medicine: a peer-reviewed, independent. Open Med. 2009;3(3):e123–e130.
  • Ali MA, Khamis Hussein S, Ali Mohamed E, et al. Diagnostic and prognostic values of miR181b-5p and miR21-5p for neonatal sepsis risk and their link to SNAP II score and disease mortality. Noncoding RNA Res. 2023;8(1):115–125. doi: 10.1016/j.ncrna.2022.11.001.
  • El-Hefnawy SM, Mostafa RG, El Zayat RS, et al. Biochemical and molecular study on serum miRNA-16a and miRNA-451 as neonatal sepsis biomarkers. Biochem Biophys Rep. 2021;25:100915. doi: 10.1016/j.bbrep.2021.100915.
  • Lin X, Wang Y. miR-141 is negatively correlated with TLR4 in neonatal sepsis and regulates LPS-induced inflammatory responses in monocytes. Braz J Med Biol Res. 2021;54(7):e10603. doi: 10.1590/1414-431x2020e10603.
  • Salim RF, Sobeih AA, Kareem HMAE. Evaluation of the clinical value of circulating miR-101, miR-187 and miR-21 in neonatal sepsis diagnosis and prognosis. Egypt J Med Hum Genet. 2020;21(1):12. doi: 10.1186/s43042-020-00052-w.
  • Liu G, Liu W, Guo J. Clinical significance of miR-181a in patients with neonatal sepsis and its regulatory role in the lipopolysaccharide-induced inflammatory response. Exp Ther Med. 2020;19(3):1977–1983. doi: 10.3892/etm.2020.8408.
  • Mao Y-Y, Su C, Fang C-C, et al. Clinical significance of the serum miR-455-5p expression in patients with neonatal sepsis. Bioengineered. 2021;12(1):4174–4182. doi: 10.1080/21655979.2021.1955580.
  • Abdelaleem OO, Mohammed SR, El Sayed HS, et al. Serum miR-34a-5p and miR-199a-3p as new biomarkers of neonatal sepsis. PLOS One. 2022;17(1):e0262339. doi: 10.1371/journal.pone.0262339.
  • Li M, Huang X, Zhuo Q, et al. Clinical significance of miR-129-5p in patients with neonatal sepsis and its regulatory role in the LPS-induced inflammatory response. Bosnian J Basic Med Sci. 2021;22(2):185–190. doi: 10.17305/bjbms2020.5184.
  • Balk RA. Systemic inflammatory response syndrome (SIRS): where did it come from and is it still relevant today? Virulence. 2014;5(1):20–26. doi: 10.4161/viru.27135.
  • Sankar V, Webster NR. Clinical application of sepsis biomarkers. J Anesth. 2013;27(2):269–283. doi: 10.1007/s00540-012-1502-7.
  • Stocker M, van Herk W, el Helou S, et al. Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns). Lancet. 2017;390(10097):871–881. doi: 10.1016/s0140-6736(17)31444-7.
  • Chiesa C, Pacifico L, Osborn JF, et al. Early-onset neonatal sepsis: still room for improvement in procalcitonin diagnostic accuracy studies. Medicine. 2015;94(30):e1230. doi: 10.1097/MD.0000000000001230.
  • Ahmad S, Ahmed MM, Hasan PMZ, et al. Identification and validation of potential miRNAs, as biomarkers for sepsis and associated lung injury: a network-based approach. Genes. 2020;11(11):1327. doi: 10.3390/genes11111327.
  • Wang J, Song J, Li Y, et al. Down-regulation of LncRNA CRNDE aggravates kidney injury via increasing MiR-181a-5p in sepsis. Int Immunopharmacol. 2020;79:105933. doi: 10.1016/j.intimp.2019.105933.
  • Chen J, Jiang S, Cao Y, et al. Altered miRNAs expression profiles and modulation of immune response genes and proteins during neonatal sepsis. J Clin Immunol. 2014;34(3):340–348. doi: 10.1007/s10875-014-0004-9.
  • Shen X, Zhang J, Huang Y, et al. Accuracy of circulating microRNAs in diagnosis of sepsis: a systematic review and meta-analysis. J Intensive Care. 2020;8(1):84. doi: 10.1186/s40560-020-00497-6.